These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6355183)

  • 1. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.
    Proud D; Togias A; Naclerio RM; Crush SA; Norman PS; Lichtenstein LM
    J Clin Invest; 1983 Nov; 72(5):1678-85. PubMed ID: 6355183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis.
    Baumgarten CR; Nichols RC; Naclerio RM; Proud D
    J Immunol; 1986 Aug; 137(4):1323-8. PubMed ID: 3637201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.
    Baumgarten CR; Nichols RC; Naclerio RM; Lichtenstein LM; Norman PS; Proud D
    J Immunol; 1986 Aug; 137(3):977-82. PubMed ID: 3522740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinins as mediators of human allergic reactions.
    Proud D; Naclerio RM; Togias AG; Kagey-Sobotka A; Adkinson NF; Norman PA; Lichtenstein LM
    Adv Exp Med Biol; 1986; 198 Pt B():181-7. PubMed ID: 3812100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis.
    Proud D; Baumgarten CR; Naclerio RM; Ward PE
    J Immunol; 1987 Jan; 138(2):428-34. PubMed ID: 2878955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P is generated in vivo following nasal challenge of allergic individuals with bradykinin.
    Baumgarten CR; O'Connor A; Dokic D; Schultz KD; Kunkel G
    Clin Exp Allergy; 1997 Nov; 27(11):1322-7. PubMed ID: 9420137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals.
    Baumgarten CR; Togias AG; Naclerio RM; Lichtenstein LM; Norman PS; Proud D
    J Clin Invest; 1985 Jul; 76(1):191-7. PubMed ID: 4019778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kininogens in nasal secretions after allergen challenge.
    Baumgarten CR; Naclerio RM; Togias AG; Lichtenstein LM; Norman PS; Proud D
    Adv Exp Med Biol; 1986; 198 Pt B():189-92. PubMed ID: 2433913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a single-dose pretreatment with captopril on the immediate response to nasal challenge with allergen.
    Proud D; Naclerio RM; Meyers DA; Kagey-Sobotka A; Lichtenstein LM; Valentine MD
    Int Arch Allergy Appl Immunol; 1990; 93(2-3):165-70. PubMed ID: 1965981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators in late antigen-induced rhinitis.
    Naclerio RM; Proud D; Togias AG; Adkinson NF; Meyers DA; Kagey-Sobotka A; Plaut M; Norman PS; Lichtenstein LM
    N Engl J Med; 1985 Jul; 313(2):65-70. PubMed ID: 2582257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
    Pipkorn U; Proud D; Lichtenstein LM; Schleimer RP; Peters SP; Adkinson NF; Kagey-Sobotka A; Norman PS; Naclerio RM
    J Clin Invest; 1987 Oct; 80(4):957-61. PubMed ID: 2443539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity.
    Juliusson S; Holmberg K; Baumgarten CR; Olsson M; Enander I; Pipkorn U
    Allergy; 1991 Aug; 46(6):459-65. PubMed ID: 1957995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
    Majchel AM; Proud D; Freidhoff L; Creticos PS; Norman PS; Naclerio RM
    J Allergy Clin Immunol; 1992 Jul; 90(1):85-91. PubMed ID: 1629510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal challenge studies with bradykinin: influence upon mediator generation.
    Brunnée T; Nigam S; Kunkel G; Baumgarten CR
    Clin Exp Allergy; 1991 Jul; 21(4):425-31. PubMed ID: 1913265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P enhances antigen-evoked mediator release from human nasal mucosa.
    Baumgarten CR; Witzel A; Kleine-Tebbe J; Kunkel G
    Peptides; 1996; 17(1):25-30. PubMed ID: 8822506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids.
    Pipkorn U; Proud D; Lichtenstein LM; Kagey-Sobotka A; Norman PS; Naclerio RM
    N Engl J Med; 1987 Jun; 316(24):1506-10. PubMed ID: 2438553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intranasal capsaicin on symptoms and mediator release.
    Bascom R; Kagey-Sobotka A; Proud D
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1323-7. PubMed ID: 1762079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat.
    Proud D; Reynolds CJ; Lacapra S; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Am Rev Respir Dis; 1988 Mar; 137(3):613-6. PubMed ID: 3345041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
    Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.